AVITA Medical Inc AVHHL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $2.03
- Day Range
- $2.63–2.63
- 52-Week Range
- $0.02–4.01
- Bid/Ask
- $2.07 / $2.39
- Market Cap
- $335.99 Mil
- Volume/Avg
- 1,095 / 919
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 7.31
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 U.S. burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the U.S. region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the U.S.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 126
- Website
- https://www.avitamedical.com
Competitors
Valuation
|
Metric
|
AVHHL
|
FPH
|
RMD
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 51.84 | 24.05 |
Price/Book Value | 5.23 | 7.91 | 5.29 |
Price/Sales | 7.31 | 8.13 | 5.34 |
Price/Cash Flow | — | 35.40 | 19.88 |
Price/Earnings
AVHHL
FPH
RMD
Financial Strength
|
Metric
|
AVHHL
|
FPH
|
RMD
|
|---|---|---|---|
Quick Ratio | 5.74 | 1.06 | 1.17 |
Current Ratio | 6.25 | 2.54 | 2.99 |
Interest Coverage | −1,243.11 | 25.77 | 21.15 |
Quick Ratio
AVHHL
FPH
RMD
Profitability
|
Metric
|
AVHHL
|
FPH
|
RMD
|
|---|---|---|---|
Return on Assets (Normalized) | −30.25% | 12.48% | 15.11% |
Return on Equity (Normalized) | −35.98% | 16.75% | 24.86% |
Return on Invested Capital (Normalized) | −35.49% | 15.46% | 18.67% |
Return on Assets
AVHHL
FPH
RMD
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
ABT
| Abbott Laboratories | Rvpxnp | $177.2 Bil | |
SYK
| Stryker Corp | Lxwqt | $110.9 Bil | |
MDT
| Medtronic PLC | Nwm | $104.6 Bil | |
BSX
| Boston Scientific Corp | Ykynv | $80.5 Bil | |
DXCM
| DexCom Inc | Msjg | $42.8 Bil | |
EW
| Edwards Lifesciences Corp | Vhglk | $40.7 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Kvz | $23.6 Bil | |
PHG
| Koninklijke Philips NV ADR | Nhhlf | $19.6 Bil | |
ALGN
| Align Technology Inc | Fdmvsh | $16.4 Bil | |
PODD
| Insulet Corp | Zpgwgss | $13.0 Bil |